Daily ShareChat: Fisher & Paykel Healthcare

By Jenny Ruth

Fisher & Paykel Healthcare's underlying performance remains strong despite a currency-related downgrade in earnings, says Forsyth Barr analyst Guy Hallwright.

The company has changed its currency assumption from 67 US cents to 74 cents for its second half and cut its earnings guidance by $10 million to between $65 million and $70 million.

"Guidance at the beginning of the year assumed a 60 cents rate, which would imply a $25 million to $30 million downgrade," Hallwright says. "A revision of only $10 million indicates that the underlying buisiness is performing better than expected."

Fisher & Paykel's first-half net profit rose 31% to $37 million.

The company has a strong growth outlook in both its obstructive sleep apnoea business (whose underlying sales rose 20% in the first half) and its respiratory and acute care products (whose first-half sales were up 14%, adjusted for $10 million in one-off sales), Hallwright says.

Expansion into new segments could potentially triple the company's addressable market, he says.

Still, Fisher & Paykel shares already trade on fairly high multiples and a lower currency is needed for the shares to perform strongly from here, he says. Hallwright is expecting a strong New Zealand dollar will persist through 2011. "With less hedging in place, this will impact profits."

BROKER CALL:  Forsyth Barr rate FPH as accumulate.

Daily ShareChat articles report how the main experts in the market might view a certain share and we provide this commentary as a useful resource for investors. Content on this site does not in any way constitute a recommendation to buy, hold or sell any particular share. Investors should always seek professional advice before making any investment decisions.

Related News

F&P Healthcare commits to third Auckland building as part of $33M spending plan
F&P Healthcare humidification products will drive earnings, Morningstar says
Record profit for Fisher & Paykel Healthcare - outlook strong
F&P Healthcare trims $23m of debt
F&P Healthcare forecasts 25% gain in 2010 profit on sales growth
Daily ShareChat: Fisher & Paykel Healthcare
Daily ShareChat: Fisher & Paykel Healthcare
F&P Healthcare stocks drops as profit forecast misses estimates
F&P Healthcare posts 76% profit jump on weaker kiwi, respirator sales
Daily ShareChat: Fisher & Paykel Healthcare

Get quotes for Fisher & Paykel Healthcare Corporation L (FPH)

NZX Annoucements for FPH

Printable version